InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the full record of transactions filed by Hatzis-Schoch Brent, Autre. Officer active across 1 company, notably Black Diamond Therapeutics, Inc.. In total, 2 reports have been recorded. Activity tracked since 12 May 2021. The latest transaction was filed on 30 January 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Hatzis-Schoch Brent
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
75,000 股0Common StockSEC:0001415889-25-002486:0
4,078 股@ US$3.20100.0% 占其流量Common StockSEC:0001104659-21-065995:0
2 条申报中的 2 条
About Hatzis-Schoch Brent
Brent Hatzis-Schoch is associated with Black Diamond Therapeutics, Inc. His role is specified in the remarks, indicating that he has specific responsibilities within the company. Brent contributes to Black Diamond's mission by bringing his expertise and experience in the field. His involvement is essential for the development and growth of the company.
